BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12553563)

  • 1. CTLA4 gene and autoimmune endocrinopathies: a new marker?
    Pociot F
    J Endocrinol Invest; 2002 Dec; 25(11):1001-5. PubMed ID: 12553563
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies, by Vaidya et al.
    Grennan DM
    Rheumatology (Oxford); 2002 Oct; 41(10):1213; author reply 1213. PubMed ID: 12364657
    [No Abstract]   [Full Text] [Related]  

  • 3. Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage.
    Tomer Y
    Thyroid; 2001 Feb; 11(2):167-9. PubMed ID: 11288987
    [No Abstract]   [Full Text] [Related]  

  • 4. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies.
    Vaidya B; Pearce S
    Eur J Endocrinol; 2004 May; 150(5):619-26. PubMed ID: 15132716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of autoimmune endocrine disease.
    Tait KF; Gough SC
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):1-11. PubMed ID: 12807496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom.
    Nithiyananthan R; Heward JM; Allahabadia A; Franklyn JA; Gough SC
    Thyroid; 2002 Jan; 12(1):3-6. PubMed ID: 11842815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis.
    Harbo HF; Celius EG; Vartdal F; Spurkland A
    Tissue Antigens; 1999 Jan; 53(1):106-10. PubMed ID: 10082437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis.
    Czaja AJ; Donaldson PT
    Immunol Rev; 2000 Apr; 174():250-9. PubMed ID: 10807521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.
    Ueda H; Howson JM; Esposito L; Heward J; Snook H; Chamberlain G; Rainbow DB; Hunter KM; Smith AN; Di Genova G; Herr MH; Dahlman I; Payne F; Smyth D; Lowe C; Twells RC; Howlett S; Healy B; Nutland S; Rance HE; Everett V; Smink LJ; Lam AC; Cordell HJ; Walker NM; Bordin C; Hulme J; Motzo C; Cucca F; Hess JF; Metzker ML; Rogers J; Gregory S; Allahabadia A; Nithiyananthan R; Tuomilehto-Wolf E; Tuomilehto J; Bingley P; Gillespie KM; Undlien DE; Rønningen KS; Guja C; Ionescu-Tîrgovişte C; Savage DA; Maxwell AP; Carson DJ; Patterson CC; Franklyn JA; Clayton DG; Peterson LB; Wicker LS; Todd JA; Gough SC
    Nature; 2003 May; 423(6939):506-11. PubMed ID: 12724780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of autoimmune thyroid disease.
    Vaidya B; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5385-97. PubMed ID: 12466323
    [No Abstract]   [Full Text] [Related]  

  • 11. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms.
    Holopainen PM; Partanen JA
    J Immunol; 2001 Sep; 167(5):2457-8. PubMed ID: 11509583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.
    Kemp EH; Ajjan RA; Husebye ES; Peterson P; Uibo R; Imrie H; Pearce SH; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):609-13. PubMed ID: 10197076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association of Ctla-4 to myasthenia gravis with thymoma.
    Huang D; Liu L; Norén K; Xia SQ; Trifunovic J; Pirskanen R; Lefvert AK
    J Neuroimmunol; 1998 Aug; 88(1-2):192-8. PubMed ID: 9688341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study.
    Holopainen P; Arvas M; Sistonen P; Mustalahti K; Collin P; Mäki M; Partanen J
    Tissue Antigens; 1999 May; 53(5):470-5. PubMed ID: 10372542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA4 variants in type 1 diabetes: some stirrups serve better backing endocrine autoimmunity.
    Badenhoop K
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):139-40. PubMed ID: 10671938
    [No Abstract]   [Full Text] [Related]  

  • 16. CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity?
    Kristiansen OP; Larsen ZM; Pociot F
    Genes Immun; 2000 Feb; 1(3):170-84. PubMed ID: 11196709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.
    Vaidya B; Imrie H; Perros P; Young ET; Kelly WF; Carr D; Large DM; Toft AD; McCarthy MI; Kendall-Taylor P; Pearce SH
    Hum Mol Genet; 1999 Jul; 8(7):1195-9. PubMed ID: 10369864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
    Kouki T; Gardine CA; Yanagawa T; Degroot LJ
    J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy.
    Young-Min S; Vaidya B
    Clin Rheumatol; 2004 Dec; 23(6):568-9. PubMed ID: 15278761
    [No Abstract]   [Full Text] [Related]  

  • 20. CTLA-4 and the genetic predisposition to autoimmunity.
    Dallos T; Kovacs L
    Bratisl Lek Listy; 2005; 106(2):55-62. PubMed ID: 16026134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.